insitro

News

AI in drug discovery & development: News watch, October 2026

Recent news in biopharma AI include a $1.5bn partnership between AstraZeneca and insitro, plus news from Iambic, DaltonTx, NVIDIA, and Chai Discovery.

News

AI in drug discovery & development: News watch, March 2026

Recent developments in the biopharma AI world include a big financing for Verily, and updates from Zealand, Latent Labs, Insilico, and BMS/insitro.

News

Lilly offers AI discovery models to biotech partners

Eli Lilly is offering AI-powered drug discovery models developed at a cost of around $1 billion to biotech companies for free.

News

Vor Bio winding down as multiple biotechs downsize

Biotech pressures exposed as big job losses are announced at Vor Bio, IGM Biosciences, Rallybio, Insitro, and Korro Bio.

News

3d rendering robot working with digital display

BMS joins forces with insitro to develop neurodegenerative t...

insitro has landed another big biopharma partnership, signing a five-year collaboration with Bristol Myers Sqibb to develop therapies for amyotrophic lateral sclerosis (ALS) and frontotempo

News

Roger Perlmutter leaves Merck after 7 years, joins board at ...

Roger Perlmutter has brought a seven-year stint as head of R&D at Merck & Co/MSD to a close, jumping ship to take on an advisory role at machine-learning specialist Insitro.

AI in drug discovery & development: News watch, October 2026

AI in drug discovery & development: News watch, March 2026

Lilly offers AI discovery models to biotech partners

Vor Bio winding down as multiple biotechs downsize

BMS joins forces with insitro to develop neurodegenerative t...

Roger Perlmutter leaves Merck after 7 years, joins board at ...

Flagship joins three biotechs together to form Etcelera

Discover a new era of healthcare panel engagement: Grounded ...

insitro

Editor's Picks